Filing Details
- Accession Number:
- 0001093557-20-000104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-13 21:28:31
- Reporting Period:
- 2020-03-11
- Accepted Time:
- 2020-03-13 21:28:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534342 | Donald Abbey | 6340 Sequence Drive San Diego CA 92121 | Evp Quality And Regulatory Aff | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-11 | 214 | $245.44 | 77,543 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-11 | 2 | $246.35 | 77,541 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-11 | 105 | $249.17 | 77,436 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-03-11 | 7,729 | $265.43 | 69,707 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $245.2069 to $246.05. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Included in this number are 31,636 restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
Billionaire Hedge Funds
